All Roll Calls
Yes: 130 • No: 0
Sponsored By: Evan J. Vickers (Republican)
Signed by Governor
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Beginning May 6, 2026, providers who offer stem cell therapy that is not FDA‑approved must give you a written notice before treatment. The notice says the therapy is not FDA‑approved and urges you to talk with your main doctor. It must be on at least 8.5×11 paper in 40‑point type and posted at the entrance and where patients can see it. Before treatment, your provider must get your signed consent that explains the treatment, FDA status, risks, benefits, and alternatives, including no treatment. Any ad for the therapy must include the same notice; in print it must match the largest text, and in other ads it must be clearly legible or clearly spoken.
Starting May 6, 2026, suppliers may give human cell or tissue products only to providers whose scope includes stem cell therapy, and only after the provider confirms in writing they will give patients the required notice. The law defines covered stem cell therapy as treatments using afterbirth placental or other human cell or tissue products, not cells taken from a fetus or embryo after an abortion. The notice and consent rules do not apply in FDA‑approved investigational trials or when the provider works for an accredited institution named in the law. Breaking these rules is unprofessional conduct and can lead to discipline.
Evan J. Vickers
Republican • Senate
Rex P. Shipp
Republican • House
All Roll Calls
Yes: 130 • No: 0
House vote • 2/25/2026
House/ passed 3rd reading
Yes: 68 • No: 0
House vote • 2/18/2026
House Comm - Favorable Recommendation
Yes: 8 • No: 0
Senate vote • 2/10/2026
Senate/ passed 3rd reading
Yes: 25 • No: 0
Senate vote • 2/9/2026
Senate/ passed 2nd reading
Yes: 26 • No: 0
House vote • 1/26/2026
Senate Comm - Favorable Recommendation
Yes: 3 • No: 0
Governor Signed
Senate/ to Governor
Senate/ received enrolled bill from Printing
Senate/ enrolled bill to Printing
Enrolled Bill Returned to House or Senate
Draft of Enrolled Bill Prepared
Bill Received from Senate for Enrolling
Senate/ signed by President/ sent for enrolling
Senate/ received from House
House/ to Senate
House/ signed by Speaker/ returned to Senate
House/ passed 3rd reading
House/ 3rd reading
House/ 2nd reading
House/ committee report favorable
House Comm - Favorable Recommendation
House/ to standing committee
House/ 1st reading (Introduced)
House/ received from Senate
Senate/ to House
Senate/ passed 3rd reading
Senate/ 3rd reading
Senate/ passed 2nd reading
Senate/ 2nd reading
Senate/ placed on 2nd Reading Calendar
Enrolled
3/3/2026
Introduced
12/29/2025